| Literature DB >> 31280829 |
Lingkan Barua1, Mithila Faruque2, Palash Chandra Banik3, Liaquat Ali4.
Abstract
OBJECTIVES: There is absolute lacking of evidences on atherogenic index of plasma (AIP) and its association with cardiovascular disease (CVD) risk factors among postmenopausal women of Bangladesh. This prompted us to investigate this association between AIP and CVD risk factors among postmenopausal women in a rural setting.Entities:
Keywords: Atherogenic index of plasma; Bangladesh; Cardiovascular risk factors; Lipid profile; Postmenopausal women
Mesh:
Year: 2019 PMID: 31280829 PMCID: PMC6620423 DOI: 10.1016/j.ihj.2019.04.012
Source DB: PubMed Journal: Indian Heart J ISSN: 0019-4832
Sociodemographic, reproductive, and behavioral characteristics of the study population, n = 265.
| Characteristics | Mean ± SD | Median (IQR) | |
|---|---|---|---|
| Age | 53.51 ± 7.5 | 52 (49–60) | |
| Education status | |||
| Illiterate | 161 (60.8) | ||
| Literate | 104 (39.2) | ||
| Occupation | |||
| Housewife | 239 (90.2) | ||
| Service holder | 26 (9.8) | ||
| Monthly income (BDT) | 12,279.34 ± 7920.26 | 10,000 (7000–15,250) | |
| Monthly income groups (BDT) | |||
| <4906 (low income) | 24 (9.1) | ||
| 4907–19,488 (lower-middle income) | 187 (70.6) | ||
| 19,489–60,252 (upper-middle income) | 53 (20) | ||
| >60,252 (high income) | 1 (0.4) | ||
| Age of menarche | 13.54 ± 1.78 | 13 (12–15) | |
| Age of onset of menopause | 44.83 ± 5.22 | 45 (40–48) | |
| Duration of menopause | 8.79 ± 6.45 | 7 (3–13) | |
| Current tobacco use | |||
| Smoking | 4 (1.5) | ||
| Smokeless | 119 (44.9) | ||
| Extra salt intake | 118 (44.5) | ||
| Physical activity levels | |||
| Active | 111 (41.9) | ||
| Inactive | 154 (58.1) | ||
| Oral contraceptive pill use | 91 (34.3) | ||
SD, standard deviation; IQR, interquartile range; BDT, Bangladeshi Taka.
According to the 2006 per-capita gross national income (GNI) and the World Bank calculation.
Tobacco use in the past 30 days.
Dietary salt intake ≥5 g per day.
Physical and biochemical parameters of cardiovascular diseases among the study population, n = 265.
| Parameters | Mean ± SD | Median (IQR) | |
|---|---|---|---|
| BMI (kg/m2) | 23.26 ± 4.74 | 23.05 (20.13–26.02) | |
| Nonobese | 245 (92.5) | ||
| Generalized obese (≥30 kg/m2) | 20 (7.5) | ||
| WHR | 0.89 ± 0.07 | 0.89 (0.85–0.94) | |
| Nonobese | 71 (26.8) | ||
| Centrally obese (>0.85) | 194 (73.2) | ||
| SBP (mmHg) | 120.56 ± 20.17 | 120 (100–140) | |
| Normal to prehypertension | 189 (71.3) | ||
| Hypertension (≥140 mmHg) | 76 (28.7) | ||
| DBP (mmHg) | 76.72 ± 11.49 | 80 (70–85) | |
| Normal to prehypertension | 189 (71.3) | ||
| Hypertension (≥90 mmHg) | 57 (21.5) | ||
| FPG (mmol/l) | 5.91 ± 2.39 | 5 (5–6) | |
| Nondiabetic | 217 (81.9) | ||
| Diabetic (≥7.0 mmol/l) | 48 (18.1) | ||
| 2-h PG (mmol/l), | 6.24 ± 1.97 | 6 (5–7) | |
| Nondiabetic | 215 (96.4) | ||
| Diabetic (≥11.0 mmol/l) | 8 (3.6) | ||
| TC (mmol/l) | 5.23 ± 1.3 | 5.12 (4.36–6.19) | |
| Desirable to borderline high | 197 (74.3) | ||
| Hypercholesterolemia (≥6.2 mmol/l) | 68 (25.7) | ||
| HDL-C (mmol/l) | 1.1 ± 0.3 | 1 (1–1) | |
| Low (<1.0 mmol/l) | 70 (26.4) | ||
| High | 195 (73.6) | ||
| LDL-C (mmol/l) | 3.19 ± 1.18 | 3 (2–4) | |
| Optimal to borderline high | 210 (79.2) | ||
| High (>4.1 mmol/l) | 55 (20.8) | ||
| TG (mmol/l) | 1.86 ± 1.13 | 2 (1–2) | |
| Normal to borderline high | 153 (57.7) | ||
| High (>2.3 mmol/l) | 112 (52.3) | ||
| AIP | 0.16 ± 0.25 | 0.13 (−0.03 to 0.32) | |
| Low risk (<0.11) | 124 (47.3) | ||
| Intermediate risk (0.11–0.24) | 45 (17.2) | ||
| High risk (>0.24) | 93 (35.5) |
SD, standard deviation; IQR, interquartile range; BMI, body mass index; WHR, waist–hip ratio; SBP, systolic blood pressure, DBP, diastolic blood pressure; FPG, fasting plasma glucose; 2-h PG, 2-h plasma glucose; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride; AIP, atherogenic index of plasma.
Association between AIP and CVD risk factors among postmenopausal rural women, n = 265.
| CVD risk factors | Standardized coefficient | |
|---|---|---|
| Age | 0.601 (−0.003 to 0.04) | 0.087 |
| Age at menopause | −0.488 (−0.043 to 0.000) | 0.053 |
| Duration of menopause | −0.606 (−0.043 to −0.001) | 0.043* |
| WHR | 0.165 (0.195–0.977) | 0.003* |
| 2-h PG | 0.118 (0.001–0.027) | 0.04* |
| TC (mmol/l) | 1.082 (0.148–0.247) | 0.000* |
| LDL-C (mmol/l) | −1.044 (−0.254 to −0.149) | 0.000* |
| MET | −0.171 (0.000–0.000) | 0.003* |
Multiple linear regression analysis was done (adjusted).
All the precisions are estimated at 95% confidence interval.
AIP, atherogenic index of plasma; CVD, cardiovascular diseases; WHR, waist–hip ratio; PG, plasma glucose; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; MET, metabolic equivalent of tasks.
*The standardized coefficient β was statistically significant at a threshold of p < 0.05.